Sun Pharmaceutical Industries Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524715	NSE Symbol:	SUNPHARMA	P/E :	94.61
ISIN Demat:	INE044A01036	Div & Yield %:	0.95	EPS :	17.85
Book Value:	101.44	Market Cap (Rs. Cr.):	405,175.70	Face Value :	1

Date	Headline
14-Jun-25	Sun Pharma updates on US FDA inspection
23-May-25	Board of Sun Pharmaceutical Industries appoints director
22-May-25	Board of Sun Pharmaceuticals Industries recommends final dividend
12-May-25	Sun Pharmaceuticals Industries announces board meeting date
24-Apr-25	Sun Pharma and Israel-based Moebius Medical publish two articles on MM-II
10-Apr-25	Sun Pharma receives favourable ruling in preliminary injunction delaying launch of LEQSELVI™
07-Apr-25	Sun Pharmaceutical launches Fexuprazan tablets 40 mg in India
18-Mar-25	Sun Pharma completes acquisition of Antibe Therapeutics Inc., Canada
10-Mar-25	Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics
17-Feb-25	Sun Pharma features in S&P Global Sustainability Yearbook 2025

Company Snapshot